Clin Mol Hepatol.
2018 Sep;24(3):294-296. 10.3350/cmh.2018.1009.
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
- Affiliations
-
- 1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. jeyyeon@hotmail.com
- KMID: 2428755
- DOI: http://doi.org/10.3350/cmh.2018.1009
Abstract
- No abstract available.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
- Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study
- New direct-acting antivirals for the treatment of chronic hepatitis C
- Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea
